Published in Cancer Res on June 01, 1999
Central role for the XRCC1 BRCT I domain in mammalian DNA single-strand break repair. Mol Cell Biol (2002) 1.64
Base excision by thymine DNA glycosylase mediates DNA-directed cytotoxicity of 5-fluorouracil. PLoS Biol (2009) 1.61
Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays. Environ Health Perspect (2003) 1.55
Functional characterization of Ape1 variants identified in the human population. Nucleic Acids Res (2000) 1.50
Kin-cohort estimates for familial breast cancer risk in relation to variants in DNA base excision repair, BRCA1 interacting and growth factor genes. BMC Cancer (2004) 1.36
Relationships among polycyclic aromatic hydrocarbon-DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environ Health Perspect (2005) 1.29
Interference of papillomavirus E6 protein with single-strand break repair by interaction with XRCC1. EMBO J (2002) 1.14
Functional polymorphisms of base excision repair genes XRCC1 and APEX1 predict risk of radiation pneumonitis in patients with non-small cell lung cancer treated with definitive radiation therapy. Int J Radiat Oncol Biol Phys (2011) 1.12
Polymorphisms of the XRCC1, XRCC3 and XPD genes and risk of colorectal adenoma and carcinoma, in a Norwegian cohort: a case control study. BMC Cancer (2006) 1.09
Polymorphisms in hOGG1 and XRCC1 and risk of prostate cancer: effects modified by plasma antioxidants. Urology (2009) 1.08
Smoking modifies the relationship between XRCC1 haplotypes and HPV16-negative head and neck squamous cell carcinoma. Int J Cancer (2009) 1.02
Single nucleotide polymorphisms in DNA repair genes might be prognostic factors in muscle-invasive bladder cancer patients treated with chemoradiotherapy. Br J Cancer (2006) 1.01
Polymorphisms of the XRCC1, XRCC3, & XPD genes, and colorectal cancer risk: a case-control study in Taiwan. BMC Cancer (2005) 1.00
A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk. Breast Cancer Res (2005) 1.00
Genetic susceptibility to lung cancer--light at the end of the tunnel? Carcinogenesis (2013) 1.00
ERCC2 2251A>C genetic polymorphism was highly correlated with early relapse in high-risk stage II and stage III colorectal cancer patients: a preliminary study. BMC Cancer (2008) 0.98
Base excision repair, aging and health span. Mech Ageing Dev (2008) 0.97
Prognostic importance of DNA repair gene polymorphisms of XRCC1 Arg399Gln and XPD Lys751Gln in lung cancer patients from India. J Cancer Res Clin Oncol (2007) 0.97
Lung cancer risk and genetic polymorphisms in DNA repair pathways: a meta-analysis. J Nucleic Acids (2010) 0.97
Polymorphisms in two DNA repair genes (XPD and XRCC1)--association with age related cataracts. Mol Vis (2011) 0.96
The molecular etiology and prevention of estrogen-initiated cancers: Ockham's Razor: Pluralitas non est ponenda sine necessitate. Plurality should not be posited without necessity. Mol Aspects Med (2013) 0.96
Genetic variation in XRCC1, sun exposure, and risk of skin cancer. Br J Cancer (2004) 0.95
Pharmacogenetics research on chemotherapy resistance in colorectal cancer over the last 20 years. World J Gastroenterol (2014) 0.91
Molecular biology of head and neck cancer: risks and pathways. Hematol Oncol Clin North Am (2008) 0.91
DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet (2007) 0.91
Polymorphisms in DNA repair genes and susceptibility to glioma in a chinese population. Int J Mol Sci (2013) 0.91
Single nucleotide polymorphisms in DNA repair genes and prostate cancer risk. Methods Mol Biol (2009) 0.90
Do genetic factors protect for early onset lung cancer? A case control study before the age of 50 years. BMC Cancer (2008) 0.89
Single-nucleotide polymorphisms in BER and HRR genes, XRCC1 haplotypes and breast cancer risk in Caucasian women. J Cancer Res Clin Oncol (2010) 0.89
Polymorphisms of XRCC1 genes and risk of nasopharyngeal carcinoma in the Cantonese population. BMC Cancer (2006) 0.88
Polymorphisms in DNA repair genes XRCC1, XRCC3 and XPD, and colorectal cancer risk: a case-control study in an Indian population. J Cancer Res Clin Oncol (2010) 0.88
Relationship between XRCC1 and XPD polymorphisms and the risk of the development of hepatocellular carcinoma: A case-control study. Exp Ther Med (2012) 0.88
Pterygium and genetic polymorphisms of the DNA repair enzymes XRCC1, XPA, and XPD. Mol Vis (2010) 0.88
A meta-analysis on XRCC1 and XRCC3 polymorphisms and colorectal cancer risk. Int J Colorectal Dis (2009) 0.88
Molecular epidemiology of DNA repair gene polymorphisms and head and neck cancer. J Biomed Res (2013) 0.88
Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck. J Exp Clin Cancer Res (2009) 0.88
Multiplex pyrosequencing of two polymorphisms in DNA repair gene XRCC1. J Mol Diagn (2006) 0.86
XRCC1 and XPD genetic polymorphisms, smoking and breast cancer risk in a Finnish case-control study. Breast Cancer Res (2005) 0.86
XRCC1 Arg399Gln gene polymorphism and the risk of systemic lupus erythematosus in the Polish population. DNA Cell Biol (2011) 0.85
Arg399Gln polymorphism of XRCC1 gene and risk of colorectal cancer in Kashmir: A case control study. Oncol Lett (2013) 0.85
ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer. Pharmgenomics Pers Med (2011) 0.85
Genetic variants of the XRCC1 gene and susceptibility to esophageal cancer: a meta-analysis. Int J Clin Exp Med (2009) 0.85
DNA repair gene ERCC1 C118T polymorphism predicts sensitivity of recurrent esophageal cancer to radiochemotherapy in a Chinese population. Thorac Cancer (2015) 0.85
Sequence variants in antioxidant defense and DNA repair genes, dietary antioxidants, and pancreatic cancer risk. Int J Mol Epidemiol Genet (2011) 0.85
Expression of a human cytochrome p450 in yeast permits analysis of pathways for response to and repair of aflatoxin-induced DNA damage. Mol Cell Biol (2005) 0.84
Gene-environment interactions between DNA repair polymorphisms and exposure to the carcinogen vinyl chloride. Biomarkers (2009) 0.84
Genetic polymorphisms in key DNA repair genes and risk of head and neck cancer in a Chinese population. Exp Ther Med (2012) 0.84
Genetic variation in DNA-repair pathways and response to radiochemotherapy in esophageal adenocarcinoma: a retrospective cohort study of the Eastern Cooperative Oncology Group. BMC Cancer (2011) 0.84
Association between single nucleotide polymorphisms (SNPs) of XRCC2 and XRCC3 homologous recombination repair genes and triple-negative breast cancer in Polish women. Clin Exp Med (2014) 0.84
Association between polymorphisms of XRCC1, p53 and MDR1 genes, the expression of their protein products and prognostic significance in human breast cancer. Med Sci Monit (2011) 0.83
Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk. Cancer (2009) 0.83
Smoking and selected DNA repair gene polymorphisms in controls: systematic review and meta-analysis. Cancer Epidemiol Biomarkers Prev (2010) 0.83
Polycyclic aromatic hydrocarbon-DNA adduct formation in prostate carcinogenesis. Cancer Lett (2005) 0.83
Part 4: pharmacogenetic variability in anticancer pharmacodynamic drug effects. Oncologist (2011) 0.82
Influence of XRCC1 Genetic Polymorphisms on Ionizing Radiation-Induced DNA Damage and Repair. J Nucleic Acids (2010) 0.82
Association between XRCC1 polymorphism 399 G->A and glioma among Caucasians: a systematic review and meta-analysis. BMC Med Genet (2012) 0.82
Influence of polymorphisms at loci encoding DNA repair proteins on cancer susceptibility and G2 chromosomal radiosensitivity. Environ Mol Mutagen (2007) 0.82
DNA repair gene XRCC1 and XPD polymorphisms and their association with coronary artery disease risks and micronucleus frequency. Heart Vessels (2007) 0.81
XRCC1 Arg399Gln and clinical outcome of platinum-based treatment for advanced non-small cell lung cancer: a meta-analysis in 17 studies. J Zhejiang Univ Sci B (2012) 0.81
Polymorphisms in DNA repair pathway genes, body mass index, and risk of non-Hodgkin lymphoma. Am J Hematol (2013) 0.81
XRCC1 genetic polymorphism Arg399Gln and gastric cancer risk: A meta-analysis. World J Gastroenterol (2008) 0.81
Polymorphisms of DNA repair genes and risk of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol (2012) 0.81
Association of polymorphisms in X-ray repair cross complementing 1 gene and risk of esophageal squamous cell carcinoma in a Chinese population. Biomed Res Int (2015) 0.81
Targeting DNA Damage Response in the Radio(Chemo)therapy of Non-Small Cell Lung Cancer. Int J Mol Sci (2016) 0.81
Predictive and prognostic markers in colorectal cancer. Gastrointest Cancer Res (2007) 0.81
Gene-environment interaction involved in cholangiocarcinoma in the Thai population: polymorphisms of DNA repair genes, smoking and use of alcohol. BMJ Open (2014) 0.81
Association of X-ray repair cross-complementing group 1 Arg194Trp, Arg399Gln and Arg280His polymorphisms with head and neck cancer susceptibility: a meta-analysis. PLoS One (2014) 0.80
Predictive assessment in pharmacogenetics of XRCC1 gene on clinical outcomes of advanced lung cancer patients treated with platinum-based chemotherapy. Sci Rep (2015) 0.80
Association of XRCC1 Arg399GIn and Tp53 Arg72Pro polymorphisms and increased risk of uterine leiomyoma - A case-control study. Genet Mol Biol (2015) 0.79
Polymorphisms in DNA repair genes and breast cancer risk in Russian population: a case-control study. Clin Exp Med (2014) 0.79
Deoxyribonucleic acid repair gene X-ray repair cross-complementing group 1 polymorphisms and non-carcinogenic disease risk in different populations: A meta-analysis. Indian J Hum Genet (2013) 0.79
Association between XRCC1 Arg399Gln polymorphism and glioma risk in a Chinese population: a case-control study. Int J Clin Exp Med (2015) 0.79
XRCC1 Arg399Gln, Arg194Trp, and Arg280His polymorphisms in esophageal cancer risk: a meta-analysis. Dig Dis Sci (2013) 0.79
Polymorphisms of DNA repair genes XRCC1 and XPD and risk of primary open angle glaucoma (POAG). Mol Vis (2007) 0.79
XRCC-1 Gene Polymorphism (Arg399Gln) and Susceptibility to Development of Lung Cancer in Cohort of North Indian Population: A Pilot Study. J Clin Diagn Res (2014) 0.79
ERCC1 Cys8092Ala and XRCC1 Arg399Gln polymorphisms predict progression-free survival after curative radiotherapy for nasopharyngeal carcinoma. PLoS One (2014) 0.78
Genetic polymorphisms of XRCC1, alcohol consumption, and the risk of colorectal cancer in Japan. J Epidemiol (2011) 0.78
Association of genetic variants in CDK6 and XRCC1 with the risk of dysplastic nevi in melanoma-prone families. J Invest Dermatol (2013) 0.78
Phase II study of satraplatin and prednisone in patients with metastatic castration-resistant prostate cancer: a pharmacogenetic assessment of outcome and toxicity. Clin Genitourin Cancer (2013) 0.78
XRCC1 gene polymorphisms in a population sample and in women with a family history of breast cancer from Rio de Janeiro (Brazil). Genet Mol Biol (2009) 0.77
Occupational exposure of workers to pesticides: Toxicogenetics and susceptibility gene polymorphisms. Genet Mol Biol (2015) 0.77
Distinct Epigenetic Effects of Tobacco Smoking in Whole Blood and among Leukocyte Subtypes. PLoS One (2016) 0.77
Characterization of Gastric Cardia Tumors: Differences in Helicobacter pylori Strains and Genetic Polymorphisms. Dig Dis Sci (2015) 0.76
Complex relationships between occupation, environment, DNA adducts, genetic polymorphisms and bladder cancer in a case-control study using a structural equation modeling. PLoS One (2014) 0.76
Genetic variations in radiation and chemotherapy drug action pathways and survival in locoregionally advanced nasopharyngeal carcinoma treated with chemoradiotherapy. PLoS One (2013) 0.76
XRCC1 Polymorphisms and Pancreatic Cancer: A Meta-Analysis. Chin J Cancer Res (2011) 0.76
XRCC1 Polymorphisms and Urinary 8-Hydroxydeoxyguanine Levels Are Associated with Urothelial Carcinoma. PLoS One (2015) 0.75
Thymidylate synthase genotype-directed chemotherapy for patients with gastric and gastroesophageal junction cancers. PLoS One (2014) 0.75
Genetic polymorphisms in XRCC1 genes and colorectal cancer susceptibility. World J Surg Oncol (2015) 0.75
Is organic farming safer to farmers' health? A comparison between organic and traditional farming. Toxicol Lett (2014) 0.75
XRCC1 Arg194Trp and Arg399Gln polymorphisms and risk of extrahepatic cholangiocarcinoma: a hospital-based case-control study in China. Int J Clin Exp Med (2015) 0.75
Association between polymorphisms in DNA repair gene XRCC1 and non-melanoma skin cancer risk: a meta-analysis. Onco Targets Ther (2017) 0.75
New single nucleotide polymorphisms (SNPs) in homologous recombination repair genes detected by microarray analysis in Polish breast cancer patients. Clin Exp Med (2016) 0.75
Nomenclature for N-acetyltransferases. Pharmacogenetics (1995) 3.59
Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev (2001) 3.43
The role of the CYP2C9-Leu359 allelic variant in the tolbutamide polymorphism. Pharmacogenetics (1996) 3.02
Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis (1998) 2.65
The prevalence of nocturia and its effect on health-related quality of life and sleep in a community sample in the USA. BJU Int (2003) 2.59
Low-cost high-resolution fast spin-echo MR of acoustic schwannoma: an alternative to enhanced conventional spin-echo MR? AJNR Am J Neuroradiol (1996) 2.24
Galactose consumption and metabolism in relation to the risk of ovarian cancer. Lancet (1989) 2.20
XPD polymorphisms: effects on DNA repair proficiency. Carcinogenesis (2000) 2.16
Intraductal papillary neoplasia of the liver associated with hepatolithiasis. Hepatology (2001) 2.07
p53 gene mutations and protein accumulation in human ovarian cancer. Proc Natl Acad Sci U S A (1993) 1.93
An association between the allele coding for a low activity variant of catechol-O-methyltransferase and the risk for breast cancer. Cancer Res (1997) 1.92
The association of human papillomavirus 16/18 infection with lung cancer among nonsmoking Taiwanese women. Cancer Res (2001) 1.90
Mutation of K-ras protooncogene in human ovarian epithelial tumors of borderline malignancy. Cancer Res (1993) 1.89
Increased risk for myelodysplastic syndromes in individuals with glutathione transferase theta 1 (GSTT1) gene defect. Lancet (1996) 1.81
Marker rescue mapping of vaccinia virus temperature-sensitive mutants using overlapping cosmid clones representing the entire virus genome. Virology (1986) 1.75
Arsenic methylation capacity, body retention, and null genotypes of glutathione S-transferase M1 and T1 among current arsenic-exposed residents in Taiwan. Mutat Res (1997) 1.69
Molecular evidence for multifocal papillary serous carcinoma of the peritoneum in patients with germline BRCA1 mutations. J Natl Cancer Inst (1998) 1.64
Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens. Arthritis Rheum (1980) 1.62
Quantitative karyotyping of human chromosomes by dual beam flow cytometry. Proc Natl Acad Sci U S A (1982) 1.62
Whole genome amplification and high-throughput allelotyping identified five distinct deletion regions on chromosomes 5 and 6 in microdissected early-stage ovarian tumors. Cancer Res (2001) 1.61
Catechol-O-methyltransferase and breast cancer risk. Carcinogenesis (1998) 1.58
Measurement and purification of human chromosomes by flow cytometry and sorting. Proc Natl Acad Sci U S A (1979) 1.58
Serum concentrations of organochlorine compounds and the subsequent development of breast cancer. Cancer Epidemiol Biomarkers Prev (1999) 1.57
The influence of lactose consumption on the association of oral contraceptive use and ovarian cancer risk. Am J Epidemiol (1991) 1.52
Bacterial characterization by flow cytometry. Science (1983) 1.52
The development of rheumatoid arthritis after recombinant hepatitis B vaccination. J Rheumatol (1998) 1.50
Identification of a novel 9 cM deletion unit on chromosome 6q23-24 in papillary serous carcinoma of the peritoneum. Hum Pathol (2000) 1.48
Elevated frequency of glycophorin A mutations in erythrocytes from Chernobyl accident victims. Radiat Res (1995) 1.48
Vitamin D levels in women with systemic lupus erythematosus and fibromyalgia. J Rheumatol (2001) 1.46
Transitional cell metaplasia of the uterine cervix and vagina: an underrecognized lesion that may be confused with high-grade dysplasia. A report of 59 cases. Am J Surg Pathol (1997) 1.44
Cigarette smoking, N-acetyltransferases 1 and 2, and breast cancer risk. Cancer Epidemiol Biomarkers Prev (1998) 1.43
Prognostic significance of DNA content in epithelial ovarian cancer. Gynecol Oncol (1994) 1.43
Human papillomavirus typing in patients with Papanicolaou smears showing squamous atypia. Gynecol Oncol (1993) 1.42
A controlled study of the effects of a supervised cardiovascular fitness training program on the manifestations of primary fibromyalgia. Arthritis Rheum (1988) 1.40
Anti-DNA autoantibody-producing hybridomas of normal human lymphoid cell origin. J Clin Invest (1984) 1.40
GSTM1, GSTT1, GSTP1, CYP1A1, and NAT1 polymorphisms, tobacco use, and the risk of head and neck cancer. Cancer Epidemiol Biomarkers Prev (2000) 1.40
The influence of humidity, sunlight, and temperature on the daytime decay of polyaromatic hydrocarbons on atmospheric soot particles. Environ Sci Technol (1988) 1.39
Patients' perceptions and responses to procedural pain: results from Thunder Project II. Am J Crit Care (2001) 1.36
Bcl-2 and p53 protein expression, apoptosis, and p53 mutation in human epithelial ovarian cancers. Am J Pathol (2000) 1.35
Polymorphisms in the DNA repair gene XRCC1 and breast cancer. Cancer Epidemiol Biomarkers Prev (2001) 1.35
Thrombosis of the deep venous drainage of the brain in adults. Analysis of seven cases with review of the literature. Arch Neurol (1995) 1.32
Hepatocellular carcinoma associated with focal nodular hyperplasia. Report of a case with clonal analysis. Virchows Arch (2001) 1.30
Glutathione S-transferase GSTT1 genotypes and susceptibility to cancer: studies of interactions with GSTM1 in lung, oral, gastric and colorectal cancers. Carcinogenesis (1996) 1.28
Engraftment and long-term expression of human fetal hemopoietic stem cells in sheep following transplantation in utero. J Clin Invest (1992) 1.28
Detailed phenotypic characterization of five temperature-sensitive mutants in the 22- and 147-kilodalton subunits of vaccinia virus DNA-dependent RNA polymerase. J Virol (1989) 1.27
Microsomal epoxide hydrolase polymorphism as a risk factor for ovarian cancer. Mol Carcinog (1996) 1.27
Evidence for increased somatic cell mutations at the glycophorin A locus in atomic bomb survivors. Science (1987) 1.27
Glutathione S-transferase genotype as a susceptibility factor in smoking-related coronary heart disease. Atherosclerosis (2000) 1.25
Mössbauer effect in the eight-iron ferredoxin from Clostridium pasterurianum. Evidence for the state of the iron atoms. Biochem J (1974) 1.25
Amplification of the EGF receptor and c-myc genes in human esophageal cancers. Int J Cancer (1988) 1.23
Association of prostate cancer with vitamin D receptor gene polymorphism. Cancer Res (1996) 1.23
Multiple DNA adducts in lymphocytes of smokers and nonsmokers determined by 32P-postlabeling analysis. Carcinogenesis (1990) 1.22
Production of human normal adult and fetal hemoglobins in Escherichia coli. Protein Eng (1997) 1.22
Glutathione S-transferase M1 (GSTM1) and T1 (GSTT1) genetic polymorphism and susceptibility to gastric and colorectal adenocarcinoma. Carcinogenesis (1996) 1.22
The NavChair Assistive Wheelchair Navigation System. IEEE Trans Rehabil Eng (1999) 1.21
Relationship between ambient air pollution and DNA damage in Polish mothers and newborns. Environ Health Perspect (1998) 1.20
The role of N-acetylation polymorphisms in smoking-associated bladder cancer: evidence of a gene-gene-exposure three-way interaction. Cancer Res (1998) 1.20
Ethnic variation in the CYP2E1 gene: polymorphism analysis of 695 African-Americans, European-Americans and Taiwanese. Pharmacogenetics (1994) 1.19
Role of aromatic amine acetyltransferases, NAT1 and NAT2, in carcinogen-DNA adduct formation in the human urinary bladder. Cancer Res (1995) 1.19
Evaluation of amitriptyline in primary fibrositis. A double-blind, placebo-controlled study. Arthritis Rheum (1986) 1.18
Measurements of the frequency of human erythrocytes with gene expression loss phenotypes at the glycophorin A locus. Hum Genet (1986) 1.18
Functional characterization of cyclooxygenase-2 polymorphisms. J Pharmacol Exp Ther (2001) 1.18
Analysis of variable region genes encoding a human anti-DNA antibody of normal origin. Implications for the molecular basis of human autoimmune responses. J Immunol (1989) 1.17
Protein kinase C heterogeneity in GH4C1 rat pituitary cells. Characterization of a Ca2(+)-independent phorbol ester receptor. J Biol Chem (1990) 1.17
A 400 kb novel deletion unit centromeric to the BRCA1 gene in sporadic epithelial ovarian cancer. Oncogene (1996) 1.16
Genetic variability in susceptibility and response to toxicants. Toxicol Lett (2001) 1.15
Chromosome classification and purification using flow cytometry and sorting. Annu Rev Biophys Biophys Chem (1986) 1.13
Is the central dogma of flow cytometry true: that fluorescence intensity is proportional to cellular dye content? Cytometry (1982) 1.13
Modulation of ppp(A2'p)nA-dependent RNase by a temperature-sensitive mutant of vaccinia virus. J Virol (1989) 1.12
Identification and characterization of variant alleles of human acetyltransferase NAT1 with defective function using p-aminosalicylate as an in-vivo and in-vitro probe. Pharmacogenetics (1998) 1.10
The prevalence of primary Sjögren's syndrome in a multiple sclerosis population. Ann Neurol (1989) 1.10
Intractable epistaxis: transantral ligation vs. embolization: efficacy review and cost analysis. Otolaryngol Head Neck Surg (1995) 1.10
Genetic instability and hematologic disease risk in Werner syndrome patients and heterozygotes. Cancer Res (2000) 1.10
Ovarian serous borderline tumors with micropapillary and cribriform patterns: a study of 40 cases and comparison with 44 cases without these patterns. Am J Surg Pathol (1999) 1.09
Anti DNA antibody production by lymphoid cells of NZB-W mice and human systemic lupus erythematosus (SLE). Clin Immunol Immunopathol (1973) 1.09
Dioxin-responsive genes: examination of dose-response relationships using quantitative reverse transcriptase-polymerase chain reaction. Cancer Res (1994) 1.08
Serous psammocarcinoma of the ovary and peritoneum. Int J Gynecol Pathol (1990) 1.08
Studies into the occurrence of soluble antigen-antibody complexes in disease. IV. Correlation between the rheumatoid biologically active factor and the clinical features of rheumatoid arthritis. Clin Exp Immunol (1969) 1.06
Immune hemolysis. I. Differing susceptibility of three genetic types of sheep red cells. J Immunol (1972) 1.06
Immunogenicity and characterization of supernatant DNA released by murine spleen cells. J Immunol (1981) 1.05
Construction of recombinant RNA templates for use as internal standards in quantitative RT-PCR. Biotechniques (1993) 1.05
Polycyclic aromatic hydrocarbon-DNA adducts in human placenta and modulation by CYP1A1 induction and genotype. Carcinogenesis (1998) 1.05
CYP1A1 mRNA levels as a human exposure biomarker: use of quantitative polymerase chain reaction to measure CYP1A1 expression in human peripheral blood lymphocytes. Carcinogenesis (1993) 1.05
Evidence for an elevated frequency of in vivo somatic cell mutations in ataxia telangiectasia. Am J Hum Genet (1989) 1.05
Putative susceptibility markers of coronary artery disease: association between VDR genotype, smoking, and aromatic DNA adduct levels in human right atrial tissue. FASEB J (1998) 1.04
Benign and borderline serous lesions of the peritoneum in women. Pathol Annu (1989) 1.04
The Diabetes Excess Weight Loss (DEWL) Trial: a randomised controlled trial of high-protein versus high-carbohydrate diets over 2 years in type 2 diabetes. Diabetologia (2012) 1.03
Prostate cancer risk and polymorphism in 17 hydroxylase (CYP17) and steroid reductase (SRD5A2). Carcinogenesis (1999) 1.03
Association between polycyclic aromatic hydrocarbon-DNA adduct levels in maternal and newborn white blood cells and glutathione S-transferase P1 and CYP1A1 polymorphisms. Cancer Epidemiol Biomarkers Prev (2000) 1.02
Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet (1996) 1.02
Septic Discitis. J Rheumatol (1981) 1.02
Perineal exposure to talc and ovarian cancer risk. Obstet Gynecol (1992) 1.01
Flow cytometric characterization of normal and variant cells with monoclonal antibodies specific for glycophorin A. J Immunol (1985) 1.01
Association between CYP17 polymorphisms and the development of breast cancer. Cancer Epidemiol Biomarkers Prev (1998) 1.01
Isolation and characterization of a novel gene induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rat liver. Carcinogenesis (1996) 1.01
Superficial endometriosis of the uterine cervix: a report of 20 cases of a process that may be confused with endocervical glandular dysplasia or adenocarcinoma in situ. Int J Gynecol Pathol (1999) 1.01
Glutathione S-transferase mu in human lymphocyte and liver: role in modulating formation of carcinogen-derived DNA adducts. Carcinogenesis (1991) 0.99
Human glutathione S-transferase P1 polymorphism and susceptibility to smoking related epithelial cancer; oral, lung, gastric, colorectal and urothelial cancer. Pharmacogenetics (1999) 0.99